During the past decade, Allied Research International Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Allied Research International Inc." are "Type I Hypersensitivity" (11 trials), "Healthy" (2 trials) and "Rhinitis, Allergic, Seasonal" (1 trials). Many other conditions were trialed in "Allied Research International Inc." in a lesser frequency.

Most popular intervention types in "Allied Research International Inc." are "Biological" (12 trials) and "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Meloxicam" (2 trials), "Placebo" (2 trials), "Ragweed MATA MPL" (2 trials), "Ragweed MATAMPL" (2 trials) and "Tree MATA MPL" (2 trials). Other intervention names were less common.

The vast majority of trials in "Allied Research International Inc." are 14 trials for "All" genders.

Currently, there are NaN active trials in "Allied Research International Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Allied Research International Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Allied Research International Inc., 5 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".